International journal of cancer. Journal international du cancer (Int J Cancer)

Journal PubWeight™ 20238.15‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. 2010 90.16
2 Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. 2014 40.30
3 Estimating the world cancer burden: Globocan 2000. 2001 16.92
4 Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. 1973 14.90
5 Establishment and characterization of a human histiocytic lymphoma cell line (U-937). 1976 14.08
6 The global health burden of infection-associated cancers in the year 2002. 2006 13.57
7 Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. 1977 11.99
8 Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. 1983 11.19
9 Statistical methods for the identification and use of prognostic factors. 1974 11.07
10 Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. 2007 10.29
11 Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). 1980 10.11
12 Estimates of the worldwide incidence of 25 major cancers in 1990. 1999 8.61
13 Global estimates of cancer prevalence for 27 sites in the adult population in 2008. 2012 7.68
14 Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. 1975 7.20
15 Against which human papillomavirus types shall we vaccinate and screen? The international perspective. 2004 6.99
16 Cancer risk in mutation carriers of DNA-mismatch-repair genes. 1999 6.73
17 Expression profiling identifies microRNA signature in pancreatic cancer. 2007 6.57
18 A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. 1976 6.48
19 Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. 1968 6.29
20 Estimates of the worldwide incidence of eighteen major cancers in 1985. 1993 6.24
21 Cancer risk in people infected with human immunodeficiency virus in the United States. 2008 6.13
22 Estimates of the worldwide mortality from 25 cancers in 1990. 1999 6.11
23 Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. 1975 5.91
24 Overview of the European and North American studies on HPV testing in primary cervical cancer screening. 2006 5.87
25 Non-producer human cells induced by murine sarcoma virus. 1975 5.82
26 Diabetes mellitus and risk of breast cancer: a meta-analysis. 2007 5.57
27 Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. 2010 5.57
28 Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. 1970 5.48
29 Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. 2011 5.43
30 Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. 1995 5.24
31 Estimates of the worldwide frequency of sixteen major cancers in 1980. 1988 5.24
32 Are there two sides to colorectal cancer? 2002 5.18
33 The urokinase-type plasminogen activator system in cancer metastasis: a review. 1997 5.01
34 Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. 2005 4.69
35 Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. 2010 4.53
36 Regulatory T cells in tumor immunity. 2010 4.53
37 Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. 1977 4.53
38 Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? 2009 4.50
39 Family history and the risk of breast cancer: a systematic review and meta-analysis. 1997 4.47
40 Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. 2009 4.45
41 Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. 1976 4.35
42 Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. 1982 4.30
43 Stromal myofibroblasts are drivers of invasive cancer growth. 2008 4.30
44 A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. 2007 4.29
45 Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. 2009 4.28
46 A classification scheme for childhood cancer. 1987 4.24
47 Smokeless tobacco use and risk of cancer of the pancreas and other organs. 2005 4.24
48 Geographic pathology revisited: development of an atlas of cancer in India. 2005 4.22
49 Inflammation and cancer: an ancient link with novel potentials. 2007 4.19
50 A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). 1986 4.11
Next 50